$390.70M
Revenue
$-75.86M
Net Income
59.19%
Gross Margin
-21.12%
Op. Margin
$79.86M
Free Cash Flow
| Breakdown | TTM (Jan 31, 2026) |
FY 2026 (Jan 31, 2026) |
FY 2024 (Jan 31, 2025) |
FY 2023 (Jan 31, 2024) |
FY 2022 (Jan 31, 2023) |
FY 2021 (Jan 31, 2022) |
|---|---|---|---|---|---|---|
| Total Revenue | $390.70M | $390.70M | $284.87M | $226.47M | $337.61M | $331.86M |
| Revenue Growth % | 0.0% | 37.2% | 25.8% | -32.9% | 1.7% | nan% |
| Cost of Revenue | $159.44M | $159.44M | $112.53M | $89.66M | $128.67M | $123.72M |
| Gross Profit | $231.27M | $231.27M | $172.33M | $136.82M | $208.93M | $208.13M |
| Gross Margin % | 59.2% | 59.2% | 60.5% | 60.4% | 61.9% | 62.7% |
| Operating Expenses | $313.79M | $313.79M | $298.93M | $291.38M | $283.19M | $237.78M |
| Research & Development | $238.52M | $238.52M | $226.11M | $215.05M | $204.95M | $167.34M |
| Selling General & Admin | $75.27M | $75.27M | $72.82M | $76.33M | $78.24M | $70.44M |
| Operating Income | $-82.53M | $-82.53M | $-126.59M | $-154.56M | $-74.26M | $-29.64M |
| Operating Margin % | -21.1% | -21.1% | -44.4% | -68.2% | -22.0% | -8.9% |
| Other Income/Expense | $8.83M | $8.83M | $8.87M | $6.03M | $3.32M | $1.00M |
| Income Before Tax | $-73.70M | $-73.70M | $-117.73M | $-148.53M | $-70.94M | $-28.64M |
| Income Tax Expense | $2.17M | $2.17M | $-602.00K | $20.89M | $-5.55M | $-2.23M |
| Net Income | $-75.86M | $-75.86M | $-117.13M | $-169.42M | $-65.39M | $-26.41M |
| Net Margin % | -19.4% | -19.4% | -41.1% | -74.8% | -19.4% | -8.0% |
| Basic EPS | nan | -1.78 | -2.84 | -4.25 | -1.70 | -0.72 |
| Diluted EPS | nan | -1.78 | -2.84 | -4.25 | -1.70 | -0.72 |
| Basic Shares Outstanding | 160K | 42.7M | 41.3M | 39.9M | 38.4M | 36.6M |
| Diluted Shares Outstanding | 160K | 42.7M | 41.3M | 39.9M | 38.4M | 36.6M |
| Breakdown | FY 2026 (Jan 31, 2026) |
FY 2024 (Jan 31, 2025) |
FY 2023 (Jan 31, 2024) |
FY 2022 (Jan 31, 2023) |
FY 2021 (Jan 31, 2022) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $191.02M | $144.62M | $144.91M | $113.54M | $171.04M |
| Accounts Receivable | $39.18M | $29.77M | $24.95M | $51.99M | $44.31M |
| Inventory | $52.25M | $34.43M | $29.04M | $40.49M | $45.22M |
| Other Current Assets | $5.84M | $6.08M | $6.23M | $5.29M | $6.17M |
| Total Current Assets | $410.27M | $320.55M | $280.16M | $304.63M | $266.75M |
| Property Plant & Equipment | $11.55M | $9.08M | $10.44M | $11.81M | $10.13M |
| Goodwill | $303.62M | $303.62M | $303.62M | $303.62M | $303.62M |
| Intangible Assets | $58.05M | $47.28M | $55.14M | $58.50M | $46.30M |
| Other Non-current Assets | $2.98M | $3.24M | $2.81M | $4.01M | $4.27M |
| Total Assets | $798.60M | $688.97M | $657.65M | $710.20M | $657.54M |
| Accounts Payable | $54.03M | $21.77M | $28.50M | $17.84M | $31.17M |
| Accrued Liabilities | $97.96M | $80.78M | $48.60M | $56.66M | - |
| Deferred Revenue | $22.39M | $14.23M | $894.00K | $1.31M | $1.41M |
| Total Current Liabilities | $177.94M | $120.99M | $82.98M | $83.46M | $89.28M |
| Deferred Tax Liabilities | $560.00K | $695.00K | - | - | - |
| Other Non-current Liabilities | $14.46M | $4.13M | $12.91M | $15.55M | $12.76M |
| Total Liabilities | $203.81M | $127.56M | $97.78M | $104.11M | $110.37M |
| Common Stock | $19.00K | $19.00K | $18.00K | $18.00K | $17.00K |
| Retained Earnings | $-327.92M | $-252.06M | $-134.93M | $34.49M | $99.87M |
| Total Stockholders Equity | $594.79M | $561.41M | $559.87M | $606.09M | $547.18M |
| Total Liabilities & Equity | $798.60M | $688.97M | $657.65M | $710.20M | $657.54M |
| Breakdown | TTM (Jan 31, 2026) |
FY 2026 (Jan 31, 2026) |
FY 2024 (Jan 31, 2025) |
FY 2023 (Jan 31, 2024) |
FY 2022 (Jan 31, 2023) |
FY 2021 (Jan 31, 2022) |
|---|---|---|---|---|---|---|
| Net Income | $-75.86M | $-75.86M | $-117.13M | $-169.42M | $-65.39M | $-26.41M |
| Depreciation & Amortization | $45.72M | $25.59M | $26.06M | $24.81M | $19.93M | $14.01M |
| Stock-based Compensation | $175.49M | $98.04M | $107.80M | $111.32M | $111.16M | $87.80M |
| Deferred Income Tax | - | $-181.00K | $-351.00K | $18.87M | - | - |
| Change in Receivables | $23.01M | $9.41M | $4.82M | $-27.04M | $7.68M | $18.60M |
| Change in Inventory | $22.16M | $17.90M | $5.21M | $-11.44M | $-4.73M | $18.94M |
| Change in Payables | $56.31M | $33.69M | $-9.58M | $10.66M | $-13.32M | $9.82M |
| Operating Cash Flow | $108.63M | $73.52M | $33.84M | $19.02M | $44.09M | $38.80M |
| Capital Expenditure | $28.77M | $15.51M | $10.38M | $11.98M | $15.05M | $9.68M |
| Acquisitions | - | - | - | - | - | $307.04M |
| Purchases of Investments | $118.17M | $62.56M | $70.67M | $34.18M | $97.44M | $118.73M |
| Sales of Investments | $54.44M | $28.90M | $19.14M | $46.94M | $2.00M | $107.76M |
| Investing Cash Flow | $-67.75M | $-30.49M | $-40.53M | $7.84M | $-107.30M | $-119.55M |
| Stock Repurchased | $3.00M | $1.00M | - | - | - | - |
| Financing Cash Flow | $1.60M | $3.81M | $6.40M | $4.51M | $5.70M | $10.53M |
| Net Change in Cash | $42.48M | $46.83M | $-292.00K | $31.37M | $-57.50M | $-70.23M |
SEC Filing Format - Data shown as it appears in the Q3 2026 (10-Q) filing
Period ended: Oct 31, 2025
Condensed Consolidated Statements of Operations
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $108.45M | - | $289.83M | - |
| Cost of Revenue | $43.87M | - | $117.48M | - |
| Gross Profit | $64.59M | - | $172.35M | - |
| Operating Expenses | $80.83M | - | $236.45M | - |
| Research & Development | $61.45M | - | $180.00M | - |
| Selling General & Admin | $19.38M | - | $56.44M | - |
| Operating Income | $-16.25M | - | $-64.09M | - |
| Other Income/Expense | $2.07M | - | $6.50M | - |
| Income Before Tax | $-14.17M | - | $-57.60M | - |
| Income Tax Expense | $933.00K | - | $1.83M | - |
| Net Income | $-15.11M | $-34.89M | $-59.43M | - |
| Basic EPS | -0.35 | - | -1.40 | - |
| Diluted EPS | -0.35 | - | -1.40 | - |
| Basic Shares Outstanding | $42.87M | - | $42.54M | - |
| Diluted Shares Outstanding | $42.87M | - | $42.54M | - |
Condensed Consolidated Balance Sheets
| Description | Oct 31, 2025 | Jan 31, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $174.06M | $144.62M |
| Accounts Receivable | $42.23M | $29.77M |
| Inventory | $39.16M | $34.43M |
| Other Current Assets | $6.54M | $6.08M |
| Total Current Assets | $383.67M | $320.55M |
| Property Plant & Equipment | $10.72M | $9.08M |
| Goodwill | $303.62M | $303.62M |
| Intangible Assets | $37.95M | $47.28M |
| Other Non-current Assets | $3.15M | $3.24M |
| Total Assets | $751.89M | $688.97M |
| Accounts Payable | $34.92M | $21.77M |
| Accrued Liabilities | $88.40M | $80.78M |
| Deferred Revenue | $17.51M | $14.23M |
| Total Current Liabilities | $144.45M | $120.99M |
| Other Non-current Liabilities | $5.41M | $4.13M |
| Total Liabilities | $161.78M | $127.56M |
| Common Stock | $19.00K | $19.00K |
| Retained Earnings | $-311.49M | $-252.06M |
| Total Stockholders Equity | $590.11M | $561.41M |
| Total Liabilities & Equity | $751.89M | $688.97M |
Condensed Consolidated Statements of Cash Flows
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-15.11M | $-34.89M | $-59.43M | - |
| Depreciation & Amortization | - | - | $19.90M | - |
| Stock-based Compensation | - | - | $77.06M | - |
| Change in Receivables | - | - | $12.46M | - |
| Change in Inventory | - | - | $4.78M | - |
| Change in Payables | - | - | $16.00M | - |
| Operating Cash Flow | - | - | $54.62M | - |
| Capital Expenditure | - | - | $11.59M | - |
| Purchases of Investments | - | - | $53.16M | - |
| Sales of Investments | - | - | $23.57M | - |
| Investing Cash Flow | - | - | $-26.10M | - |
| Stock Repurchased | - | - | $1.00M | - |
| Financing Cash Flow | - | - | $1.35M | - |
| Net Change in Cash | - | - | $29.87M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.